Key result
Hemodialysis is linked to significantly elevated plasma angiotensin-converting enzyme activity in chronic renal failure.
Why the study?
The changes in plasma angiotensin-converting enzyme activity during routine hemodialysis in patients with end stage renal failure were not well characterized.
Does routine hemodialysis alter plasma angiotensin-converting enzyme activity in patients with end stage renal failure?
Observational
Does routine hemodialysis alter plasma angiotensin-converting enzyme activity in patients with end stage renal failure?
Plasma angiotensin-converting enzyme activity increases during hemodialysis and correlates with early decreases in white blood cell count, suggesting potential utility in assessing transient pulmonary dysfunction.
ACE activity rises during hemodialysis; hypothesis-generating for pulmonary effects in ESRD, needs prospective confirmation.
Plasma angiotensin-converting enzyme activity was measured by spectrophotometer in normal subjects and in patients with end stage renal failure, serially during a routine hemodialysis. Patients on maintenance hemodialysis tended to be associated with elevated plasma angiotensin-converting enzyme activity versus normal subjects. Plasma angiotensin-converting enzyme activity was significantly elevated in patients with chronic renal failure after 5 hours of hemodialysis(p<.001). Plasma angiotensin-converting enzyme activity corrected for hemoconcentration was also significantly increased(p<.05). There was a significant correlation between the increase in plasma angiotensin-converting enzyme activity after 5 hours of hemodialysis and the decrease in white blood cell count at one hour of hemodialysis (r = 0.51, p<.05). It is suggested that plasma angiotensin-converting enzyme analysis may prove to be a method for assessing transient pulmonary dysfunction during hemodialysis.
No takes yet. Share an insight, caveat, or question.
Koo et al. (1987) conducted an observational in End stage renal failure. Hemodialysis vs. Normal subjects / pre-hemodialysis baseline was evaluated on Plasma angiotensin-converting enzyme activity (p=<.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: